Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15


The Role of Muscarinic Receptors in the Pathophysiology of Mood Disorders: A Potential Novel Treatment?

Jeon WJ, Dean B, Scarr E, Gibbons A.

Curr Neuropharmacol. 2015;13(6):739-49. Review.


Changes in Muscarinic M2 Receptor Levels in the Cortex of Subjects with Bipolar Disorder and Major Depressive Disorder and in Rats after Treatment with Mood Stabilisers and Antidepressants.

Gibbons AS, Jeon WJ, Scarr E, Dean B.

Int J Neuropsychopharmacol. 2016 Apr 20;19(4). pii: pyv118. doi: 10.1093/ijnp/pyv118. Print 2016 Apr.


Therapygenetics in mindfulness-based cognitive therapy: do genes have an impact on therapy-induced change in real-life positive affective experiences?

Bakker JM, Lieverse R, Menne-Lothmann C, Viechtbauer W, Pishva E, Kenis G, Geschwind N, Peeters F, van Os J, Wichers M.

Transl Psychiatry. 2014 Apr 22;4:e384. doi: 10.1038/tp.2014.23.


Neural and genetic correlates of binge drinking among college women.

Bauer LO, Ceballos NA.

Biol Psychol. 2014 Mar;97:43-8. doi: 10.1016/j.biopsycho.2014.01.005. Epub 2014 Feb 14.


GABRA2 and KIBRA genotypes predict early relapse to substance use.

Bauer LO, Covault J, Gelernter J.

Drug Alcohol Depend. 2012 Jun 1;123(1-3):154-9. doi: 10.1016/j.drugalcdep.2011.11.004. Epub 2011 Nov 29.


Expression profiling of a genetic animal model of depression reveals novel molecular pathways underlying depressive-like behaviours.

Blaveri E, Kelly F, Mallei A, Harris K, Taylor A, Reid J, Razzoli M, Carboni L, Piubelli C, Musazzi L, Racagni G, Mathé A, Popoli M, Domenici E, Bates S.

PLoS One. 2010 Sep 7;5(9):e12596. doi: 10.1371/journal.pone.0012596.


Genetic variation in cholinergic muscarinic-2 receptor gene modulates M2 receptor binding in vivo and accounts for reduced binding in bipolar disorder.

Cannon DM, Klaver JK, Gandhi SK, Solorio G, Peck SA, Erickson K, Akula N, Savitz J, Eckelman WC, Furey ML, Sahakian BJ, McMahon FJ, Drevets WC.

Mol Psychiatry. 2011 Apr;16(4):407-18. doi: 10.1038/mp.2010.24. Epub 2010 Mar 30.


Depression Case Control (DeCC) Study fails to support involvement of the muscarinic acetylcholine receptor M2 (CHRM2) gene in recurrent major depressive disorder.

Cohen-Woods S, Gaysina D, Craddock N, Farmer A, Gray J, Gunasinghe C, Hoda F, Jones L, Knight J, Korszun A, Owen MJ, Sterne A, Craig IW, McGuffin P.

Hum Mol Genet. 2009 Apr 15;18(8):1504-9. doi: 10.1093/hmg/ddp051. Epub 2009 Jan 30.


Decreased muscarinic receptor binding in the frontal cortex of bipolar disorder and major depressive disorder subjects.

Gibbons AS, Scarr E, McLean C, Sundram S, Dean B.

J Affect Disord. 2009 Aug;116(3):184-91. doi: 10.1016/j.jad.2008.11.015. Epub 2008 Dec 21.


Association of CHRM2 with IQ: converging evidence for a gene influencing intelligence.

Dick DM, Aliev F, Kramer J, Wang JC, Hinrichs A, Bertelsen S, Kuperman S, Schuckit M, Nurnberger J Jr, Edenberg HJ, Porjesz B, Begleiter H, Hesselbrock V, Goate A, Bierut L.

Behav Genet. 2007 Mar;37(2):265-72. Epub 2006 Dec 12.


CHRM2 gene predisposes to alcohol dependence, drug dependence and affective disorders: results from an extended case-control structured association study.

Luo X, Kranzler HR, Zuo L, Wang S, Blumberg HP, Gelernter J.

Hum Mol Genet. 2005 Aug 15;14(16):2421-34. Epub 2005 Jul 6.


Evidence of common and specific genetic effects: association of the muscarinic acetylcholine receptor M2 (CHRM2) gene with alcohol dependence and major depressive syndrome.

Wang JC, Hinrichs AL, Stock H, Budde J, Allen R, Bertelsen S, Kwon JM, Wu W, Dick DM, Rice J, Jones K, Nurnberger JI Jr, Tischfield J, Porjesz B, Edenberg HJ, Hesselbrock V, Crowe R, Schuckit M, Begleiter H, Reich T, Goate AM, Bierut LJ.

Hum Mol Genet. 2004 Sep 1;13(17):1903-11. Epub 2004 Jun 30.


Association of the muscarinic cholinergic 2 receptor (CHRM2) gene with major depression in women.

Comings DE, Wu S, Rostamkhani M, McGue M, Iacono WG, MacMurray JP.

Am J Med Genet. 2002 Jul 8;114(5):527-9.


Supplemental Content

Loading ...
Support Center